Evidence map›Paper›PMID 33990883›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2021

High flow nasal therapy in the management of hypoxemic dyspnea at the end of life.

Sebastiano Mercadante, Fausto Giuliana

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sebastiano MercadanteMain Regional Center for Pain Relief & Supportive/Palliative Care, La Maddalena Cancer Center, Palermo, Italy. Terapiadeldolore@lamaddalenanet.it.ORCID http://orcid.org/0000-0001-9859-6487
Fausto GiulianaMain Regional Center for Pain Relief & Supportive/Palliative Care, La Maddalena Cancer Center, Palermo, Italy.
La Maddalena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Refractory dyspnea is challenging for physicians treating patients near to the end of life. High-flow nasal therapy (HFNT). We report a case in which HFNS was effective in a patient in the last days of life to mitigate dyspnea allowing a minimal quality of life for some days before dying. HFNT may be helpful for severely hypoxemic patients who are unresponsive to common measured adopted in the last weeks-days of life of advanced cancer patients. Future studies should assess an early use of this device in combination with lower doses of opioids or as an alternative.

Indexed as

Oxygen Inhalation TherapyQuality of LifeAnalgesics, OpioidDeathDyspneaHumansAnalgesics, OpioidAdvanced cancerDyspneaEnd of lifeHigh-flow nasal therapyNon-invasive ventilationOpioids

Identifiers

PMID33990883
PMCPMC8121635
OpenAlexW3160227312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.